Материалы международной конференции 2013, Т. 3, № 2 Since 1982, MMR vaccinations against measles, mumps and rubella have belonged to the national vaccination program in Finland. <...> A goal of these vaccinations was to eliminate all the three diseases. <...> For monitoring a progress of this goal an enhanced surveillance of measles, mumps and rubella was started along with the MMR vaccinations. <...> The active investigations of suspected measles, mumps and rubella cases showed a rapid decline in the incidence of all the three diseases soon after the launchment of the nationwide MMR vaccinations. <...> The enhanced surveillance also revealed that clinical diagnosis is not always reliable, particularly when measles, mumps or rubella is suspected in vaccinated individual. <...> The high MMR vaccination coverage was reached in the end of 1980s and indigenous measles, mumps and rubella were eliminated by the mid of 1990s from Finland. <...> After the elimination of measles, mumps and rubella the importations of these diseases continued. <...> Therefore, case-based laboratory surveillance and molecular epidemiological investigations became necessary to provide the required data in the elimination setting. <...> Molecular epidemiological characterization of sporadic cases has helped to identify the sources of imported cases and revealed that different genotypes of these diseases were imported over time to Finland. <...> In general, imported cases have not spread in the population, besides year 2011 when two clusters of import-related cases of measles were diagnosed. <...> The two separate clusters were caused by the D4 genotypes of measles virus, imported from other European countries; while two other imported measles cases in the same year were caused by other genotypes (D8 and G3) of measles virus. <...> Enhanced laboratory surveillance and molecular epidemiological investigations of all measles, mumps and rubella viruses are indispensable for following and assuring the achieved elimination in Finland. <...> CO-CIRCULATION AND MACRO-EVOLUTION OF POLIOVIRUSES AND OTHER ENTEROVIRUSES OF SPECIES C F. Delpeyroux, S.A. Sadeuh-Mba, M. Bessaud, D. Massenet, M.-L. Joffret, M.-C. Endegue, R. Njouom, J.-M. Reynes, C. Burns, J. Shaw, D. Rousset Institut Pasteur, Paris, France Centre Pasteur, Cameroon Center for Disease Control, Atlanta, Georgia, USA Virtually all pathogenic circulating vaccinederived polioviruses (cVDPVs) that have been fully characteri zed, including those found <...>